Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
about
Self-assembly of dinuclear Pd(ii)/Pt(ii) metallacyclic receptors incorporating N-heterocyclic carbene complexes as corners.Synthesis, structures and biomolecular interactions of new silver(i) 5,5-diethylbarbiturate complexes of monophosphines targeting Gram-positive bacteria and breast cancer cells.Gold (I) N-heterocyclic carbene complex inhibits mouse melanoma growth by p53 upregulation.Cytotoxicity of Pyrazine-Based Cyclometalated (C^Npz^C)Au(III) Carbene Complexes: Impact of the Nature of the Ancillary Ligand on the Biological Properties.Photoexpulsion of surface-grafted ruthenium complexes and subsequent release of cytotoxic cargos to cancer cells from mesoporous silica nanoparticles.N-heterocyclic carbene gold(I) and silver(I) complexes bearing functional groups for bio-conjugation.Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer PropertiesBiological Screening of Newly Synthesized BIAN N-Heterocyclic Gold Carbene Complexes in Zebrafish Embryos.Targeting Antioxidant Pathways with Ferrocenylated N-Heterocyclic Carbene Supported Gold(I) Complexes in A549 Lung Cancer Cells.Versatile synthesis of cationic N-heterocyclic carbene-gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents.Titanocene-Gold Complexes Containing N-Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro.Gold-catalyzed reaction of oxabicyclic alkenes with electron-deficient terminal alkynes to produce acrylate derivatives.N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug DeliveryAnti-proliferative and anti-tumor activity of silver(I) compounds.A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds.Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes.Gold(III) complexes in medicinal chemistry.Coinage Metal Complexes of the Carbenic Tautomer of a Conjugated Mesomeric Betaine Akin to Nitron.A multi-functional PEGylated gold(iii) compound: potent anti-cancer properties and self-assembly into nanostructures for drug co-deliveryMitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State.Luminescent bioactive NHC-metal complexes to bring light into cells.Sugar-boronate ester scaffold tethered pyridyl-imine palladium(II) complexes: synthesis and their in vitro anticancer evaluation.4-Alkylated Silver-N-Heterocyclic Carbene (NHC) Complexes with Cytotoxic Effects in Leukemia Cells.Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents.Highly cytotoxic bioconjugated gold(I) complexes with cysteine-containing dipeptides.Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme.Luminescent ruthenium(II) complex bearing bipyridine and N-heterocyclic carbene-based C∧N∧C pincer ligand for live-cell imaging of endocytosis.Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes.Gold(I) thiolates containing amino acid moieties. Cytotoxicity and structure-activity relationship studies.Targeting cytotoxicity and tubulin polymerization by metal-carbene complexes on a purine tautomer platform.Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity.Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes.A binuclear gold(I) complex with mixed bridging diphosphine and bis(N-heterocyclic carbene) ligands shows favorable thiol reactivity and inhibits tumor growth and angiogenesis in vivo.'Auto-click' functionalization for diversified copper(I) and gold(I) NHCs.Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potential.Palladium(II) complexes with N-heteroaromatic bidentate hydrazone ligands: the effect of the chelate ring size and lipophilicity on in vitro cytotoxic activity.Imidazolium and benzimidazolium-containing compounds: from simple toxic salts to highly bioactive drugs.Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
P2860
Q31171348-9E861DB8-4080-42BA-A5FB-675A20BF9F4EQ32175273-72BE4BC2-C06F-4998-82C1-B599F29E5B50Q33557744-0C364BF9-F036-4554-9416-074B48248C5BQ33696556-D5937A0F-8616-4C2B-BD87-4A35C4883287Q33862903-E23FCDD8-D65B-4CC1-968F-F51F5FF92914Q35504676-F93AEF14-B278-4CDA-BC57-BCC24AA33F80Q35961028-27355236-4C65-4CF7-8B4F-8F633FDA9022Q36247456-5820745D-BE72-42C9-8320-41458736447DQ36604338-6B3DAC44-69A2-47CB-A598-8552DA4EA7AAQ36883542-F9D7FA01-2A77-4755-966B-DE4808AA8242Q36890078-57820889-ED8B-4A50-9898-DD0D25CFD96BQ37279834-C69CB3DA-8630-467E-A9A9-1242E76993BCQ37603242-58342E85-C2D7-4F56-A2AA-4BE111258A5FQ38101252-9931BF63-F097-45E9-94EF-1A6A124865C4Q38162354-B5C4C9DD-E2BC-4771-85CD-22E904B0BBF9Q38199383-5B67C286-2A01-4653-83CB-8236B9249262Q38203819-1E56AE6F-6DE4-48F8-9A21-C0348EBC90AEQ38264535-B9C84E00-2B91-439F-9B7E-5223CA2A3CE7Q38689577-EAF96534-FED5-4D5B-B577-6C3547CFF943Q38705760-AF3C769C-3108-4E04-9BA0-19D676A3949EQ38786513-86DE8836-44FD-4C46-A7A8-6D9473D5E316Q38814705-979702F9-58E9-4DCC-8AF8-2AA8D8C8E636Q38833511-64A62DDA-A279-411E-A77B-9C1528F5938AQ38845686-5E0E1E10-94DB-4A0C-AC25-4CD19D549D9AQ38850175-FE053EDE-44F5-486B-91E6-DBE7D15F46B8Q38860140-03208CAF-6EDE-4559-8EDF-2083CDB30CEAQ38865464-8FA79448-123B-4753-8CDF-8925B80358C4Q38900592-D39EA65E-1958-4744-BB36-EEBE631E7F34Q38942097-50DA8D84-E865-411A-9A13-9E2976E00086Q38949131-9E4C2218-0D5A-4862-9A14-23FC01411850Q38992529-8FB6AC86-4B3C-4679-96CA-56FD012BA1BBQ38993875-C6159DC8-5754-4D05-94AA-DD0380D3FCDCQ38999673-3EE08F58-509E-42B7-BD7C-A2BC43C58834Q39004496-A5FA794B-6C80-40D5-B8EC-29220DFE672BQ39008735-0B71E06F-5B3B-423A-8190-59EE141B71A7Q39013723-8CBF56F1-CA12-4F9D-BD8C-60DE3E80CB2AQ39014722-69033257-51E1-48D9-93F8-3172778525C7Q39065508-55FCAFA2-E655-401F-80C9-8EBC93BA7D0FQ39066072-2343FA14-E997-4DD8-A161-26309E110936Q39068148-61694C58-76AD-4C72-A1E4-18EFC19FE07F
P2860
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
@en
type
label
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
@en
prefLabel
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
@en
P356
P1476
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
@en
P2093
Ronald Gust
P304
P356
10.1039/C2CS35314H
P577
2013-01-01T00:00:00Z